179 related articles for article (PubMed ID: 33539530)
1. Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases.
Satu MS; Khan MI; Rahman MR; Howlader KC; Roy S; Roy SS; Quinn JMW; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1415-1429. PubMed ID: 33539530
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.
Nashiry MA; Sumi SS; Sharif Shohan MU; Alyami SA; Azad AKM; Moni MA
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33993223
[TBL] [Abstract][Full Text] [Related]
3. Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients.
Taz TA; Ahmed K; Paul BK; Al-Zahrani FA; Mahmud SMH; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1451-1465. PubMed ID: 33611340
[TBL] [Abstract][Full Text] [Related]
4. Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients.
Taz TA; Ahmed K; Paul BK; Kawsar M; Aktar N; Mahmud SMH; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1254-1266. PubMed ID: 33024988
[TBL] [Abstract][Full Text] [Related]
5. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
Nashiry A; Sarmin Sumi S; Islam S; Quinn JMW; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1387-1401. PubMed ID: 33458761
[TBL] [Abstract][Full Text] [Related]
7. Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart.
Bräuninger H; Stoffers B; Fitzek ADE; Meißner K; Aleshcheva G; Schweizer M; Weimann J; Rotter B; Warnke S; Edler C; Braun F; Roedl K; Scherschel K; Escher F; Kluge S; Huber TB; Ondruschka B; Schultheiss HP; Kirchhof P; Blankenberg S; Püschel K; Westermann D; Lindner D
Cardiovasc Res; 2022 Jan; 118(2):542-555. PubMed ID: 34647998
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
Mahmud SMH; Al-Mustanjid M; Akter F; Rahman MS; Ahmed K; Rahman MH; Chen W; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33847347
[TBL] [Abstract][Full Text] [Related]
9. Network based approach to identify interactions between Type 2 diabetes and cancer comorbidities.
Nayan SI; Rahman MH; Hasan MM; Raj SMRH; Almoyad MAA; Liò P; Moni MA
Life Sci; 2023 Dec; 335():122244. PubMed ID: 37949208
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
[TBL] [Abstract][Full Text] [Related]
11. Human coronaviruses in idiopathic Parkinson's disease: Implications of SARS-CoV-2's modulation of the host's transcriptome.
Vavougios GD
Infect Genet Evol; 2021 Apr; 89():104733. PubMed ID: 33516970
[TBL] [Abstract][Full Text] [Related]
12. Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes.
Islam MB; Chowdhury UN; Nain Z; Uddin S; Ahmed MB; Moni MA
Comput Biol Med; 2021 Sep; 136():104668. PubMed ID: 34340124
[TBL] [Abstract][Full Text] [Related]
13. IFI44 is an immune evasion biomarker for SARS-CoV-2 and
Zheng Q; Wang D; Lin R; Lv Q; Wang W
Front Immunol; 2022; 13():1013322. PubMed ID: 36189314
[TBL] [Abstract][Full Text] [Related]
14. Potential core genes associated with COVID-19 identified via weighted gene co-expression network analysis.
Wu C; Wu Z; Chen Y; Huang X; Tian B
Swiss Med Wkly; 2022 Nov; 152():40033. PubMed ID: 36509426
[TBL] [Abstract][Full Text] [Related]
15. Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.
Zhang W; Liu L; Xiao X; Zhou H; Peng Z; Wang W; Huang L; Xie Y; Xu H; Tao L; Nie W; Yuan X; Liu F; Yuan Q
Front Immunol; 2023; 14():961642. PubMed ID: 37026010
[TBL] [Abstract][Full Text] [Related]
16. Novel signaling pathways regulate SARS-CoV and SARS-CoV-2 infectious disease.
Cheng LC; Kao TJ; Phan NN; Chiao CC; Yen MC; Chen CF; Hung JH; Jiang JZ; Sun Z; Wang CY; Hsu HP
Medicine (Baltimore); 2021 Feb; 100(7):e24321. PubMed ID: 33607766
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 disease and malignant cancers: The impact for the
Li D; Liu X; Zhang L; He J; Chen X; Liu S; Fu J; Fu S; Chen H; Fu J; Cheng J
Int J Biol Sci; 2021; 17(14):3954-3967. PubMed ID: 34671211
[TBL] [Abstract][Full Text] [Related]
18. Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids.
Fang KY; Cao WC; Xie TA; Lv J; Chen JX; Cao XJ; Li ZW; Deng ST; Guo XG
Hum Genomics; 2021 Mar; 15(1):18. PubMed ID: 33726831
[TBL] [Abstract][Full Text] [Related]
19. Network Pharmacology Reveals That Resveratrol Can Alleviate COVID-19-Related Hyperinflammation.
Xiao Z; Ye Q; Duan X; Xiang T
Dis Markers; 2021; 2021():4129993. PubMed ID: 34580601
[TBL] [Abstract][Full Text] [Related]
20. Identification of Differentially Expressed Genes in COVID-19 and Integrated Bioinformatics Analysis of Signaling Pathways.
Fang L; Tang T; Hu M
Genet Res (Camb); 2021; 2021():2728757. PubMed ID: 35002537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
